BiotechTube
Home/Bioxodes/Philippe Monteyne
PM

Philippe Monteyne

Chairman of the Board

Bioxodes

Therapeutic Areas

StrokeThrombo-inflammatory DiseasesNeuroinflammation

Bioxodes Pipeline

DrugIndicationPhase
BIOX-101 (Ir-CPI)Intracerebral Hemorrhage (ICH)Phase 2b (preparing)
Pipeline candidatesChronic Thrombo-inflammatory & Inflammatory DiseasesDiscovery/Pre-clinical

Leadership Team at Bioxodes

MD
Marc Dechamps
Chief Executive Officer
View full Bioxodes profile